TB-500, and copper peptide to build muscle, rejuvenate skin, and boost longevity. But do they work and are they safe?

Voyxact, an APRIL inhibitor, receives FDA accelerated approval for adults with primary IgA nephropathy to reduce proteinuria.

As state health departments report more botulism-like illnesses, consumers have easy access to unapproved products and information on how to self-inject.

Three of the victims required intubation and a ventilator, according to a health advisory to medical providers published ...

The use of injectable peptides for a range of perceived health benefits is surging, fueled by aggressive marketing campaigns ...

It's the law of unintended consequences: equipping browsers with agentic AI opens the door to an exponential volume of prompt ...

Imagine treating a brain disease with a jab in the arm instead of a hole in the skull. That’s the future a team at MIT is sketching out with a technology they call Circulatronics. It’s a mash-up of ...

SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- A peer-reviewed article by researchers at the University of Shanghai for Science and Technology (USST), published in an international biomedical engineering ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a once-monthly injection of Eli Lilly’s Omvoh for maintenance therapy in adult patients ...

PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis ® intradermal (ID) Needle-free Injection System overcomes ...